Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT06041555
Recruiting
MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
Not applicable · France · 1 site
Registry update: 20 Feb 2024
NCT07395037
Recruiting
A Study of Ward Admissions for Haematuria
Not applicable · United Kingdom · 1 site
Registry update: 9 Feb 2026
NCT07326280
Recruiting
The Cold Ischemia Robot-assisted Partial Nephrectomy
Not applicable · China · 1 site
Registry update: 8 Jan 2026
NCT07167329
Recruiting
Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial
Phase 2 · Brazil · 1 site
Registry update: 11 Sept 2025
NCT04974671
Recruiting
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
Phase 2 · United States · 1 site
Registry update: 4 Dec 2025
NCT05931393
Recruiting
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
Phase 2 · United States · 1 site
Registry update: 23 Oct 2026
NCT05770037
Recruiting
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
Phase 2/3 · United Kingdom · 27 sites
Registry update: 24 Nov 2025
NCT06255223
Recruiting
A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
Phase 2 · China · 1 site
Registry update: 3 Sept 2025
NCT06101290
Recruiting
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
Not applicable · United States · 1 site
Registry update: 30 Jun 2026
NCT05969496
Recruiting
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Phase 2 · United States · 3 sites
Registry update: 13 Apr 2026
NCT05830058
Recruiting
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Phase 2 · United States · 2 sites
Registry update: 4 Nov 2026
NCT06047379
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/2 · United States · 8 sites
Registry update: 24 Sept 2026
NCT06004336
Recruiting
A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)
Phase 2 · United States · 1 site
Registry update: 16 Jul 2026
NCT06047600
Recruiting
Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126)
Not applicable · France · 11 sites
Registry update: 19 Jun 2025
NCT06026410
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Phase 1 · Germany, Spain, France, Italy, United States · 37 sites
Registry update: 14 Oct 2026
NCT05783908
Recruiting
Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
Not applicable · France · 1 site
Registry update: 17 Feb 2025
NCT06327178
Recruiting
Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.
Not applicable · China · 1 site
Registry update: 25 May 2025
NCT05969860
Recruiting
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · United States · 2 sites
Registry update: 6 Nov 2026
NCT06035211
Recruiting
Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery- Rein 3D Anxiety
Not applicable · France · 6 sites
Registry update: 15 Jun 2025
NCT05865002
Recruiting
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · India · 37 sites
Registry update: 17 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.